Denis Antoine, M.D., FAPA, FASAM, applies the Life Story Perspective to re-think approaches to mental illness and substance use disorder treatments in order to improve individual and societal outcomes.
Roland Griffiths, director of Johns Hopkins Center for Consciousness and Psychedelic Research, describes a milestone study showing that psilocybin relieves major depression.
The largest prospective study on naturalistic psilocybin use found improvements in mental health and well-being in those who took the drug outside of clinical trial settings.
A Johns Hopkins study shows that virtual group meetings held in partnership with early childhood learning centers offer participants valuable support and social connection.
Welcome to Clinical Connection
The content on this web site is intended for physicians. Patients, please visit hopkinsmedicine.org to learn more about Johns Hopkins patient care and services.
Physicians, discover the latest in biomedical research and clinical innovation from Johns Hopkins experts. Enjoy educational videos and engaging peer-to peer articles, and learn about clinical trials and CME courses available from our world-renowned institution.
For patients-please visit hopkinsmedicine.org to learn more about Johns Hopkins patient care and services.